Christian Hordo
Corporate Officer/Principal bij SANA BIOTECHNOLOGY, INC.
Vermogen: 7 M $ op 30-04-2024
Profiel
Christian Hordo is currently the Chief Business Officer & Executive Vice President at Sana Biotechnology, Inc. Prior to this, he was the Vice President at Juno Therapeutics, Inc. from 2015 to 2018.
Mr. Hordo completed his undergraduate degree at McGill University, his graduate degree at the University of Toronto, and holds an MBA from Harvard Business School.
Bekende belangen in openbare bedrijven
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
SANA BIOTECHNOLOGY, INC.
0.39% | 07-03-2024 | 867 455 ( 0.39% ) | 7 M $ | 30-04-2024 |
Actieve functies van Christian Hordo
| Bedrijven | Functie | Begin |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Corporate Officer/Principal | 01-10-2018 |
Eerdere bekende functies van Christian Hordo
| Bedrijven | Functie | Einde |
|---|---|---|
| JUNO THERAPEUTICS INC | Corporate Officer/Principal | 01-10-2018 |
Opleiding van Christian Hordo
| Harvard Business School | Masters Business Admin |
| University of Toronto | Graduate Degree |
| McGill University | Undergraduate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| SANA BIOTECHNOLOGY, INC. | Health Technology |
| Bedrijven in privébezit | 1 |
|---|---|
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Juno Therapeutics, Inc. is a biopharmaceutical company, which engages in the development of innovative cellular immunotherapy for the treatment of cancer. It offers platforms which includes chimeric antigen receptors and T-cell receptors. The company was founded by Hans Edgar Bishop, Lawrence Corey, Richard D. Klausner, Stan Riddell, Isabelle Riviere, and Robert Taylor Nelsen on August 5, 2013 and is headquartered in Seattle, WA. | Health Technology |
